Interact to see
Advertisement
Advertisement
CURE vs SPXL
CURE vs SPXL Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
CURE vs. SPXL commentary
Jul 06, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURE is a Buy and SPXL is a Buy.
SUMMARIES
FUNDAMENTALS
Fundamentals
SPXL has more net assets: 5.68B vs. CURE (136M). SPXL has a higher annual dividend yield than CURE: SPXL (7.076) vs CURE (-12.980). CURE was incepted earlier than SPXL: CURE (14 years) vs SPXL (17 years). SPXL (0.87) has a lower expense ratio than CURE (0.93). SPXL has a higher turnover CURE (23.00) vs CURE (23.00).
| CURE | SPXL | CURE / SPXL | |
| Gain YTD | -12.980 | 7.076 | -183% |
| Net Assets | 136M | 5.68B | 2% |
| Total Expense Ratio | 0.93 | 0.87 | 107% |
| Turnover | 23.00 | 29.00 | 79% |
| Yield | 1.40 | 0.91 | 153% |
| Fund Existence | 14 years | 17 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| CURE | SPXL | |
|---|---|---|
| RSI ODDS (%) | N/A | 4 days ago 88% |
| Stochastic ODDS (%) | 4 days ago 90% | 4 days ago 87% |
| Momentum ODDS (%) | 4 days ago 84% | 4 days ago 90% |
| MACD ODDS (%) | N/A | 4 days ago 90% |
| TrendWeek ODDS (%) | 4 days ago 90% | 4 days ago 90% |
| TrendMonth ODDS (%) | 4 days ago 90% | 4 days ago 90% |
| Advances ODDS (%) | 11 days ago 90% | 4 days ago 90% |
| Declines ODDS (%) | 17 days ago 90% | 17 days ago 89% |
| BollingerBands ODDS (%) | 4 days ago 86% | 4 days ago 85% |
| Aroon ODDS (%) | 4 days ago 90% | 4 days ago 90% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RFMZ | 12.76 | 0.05 | +0.39% |
| RiverNorth Flexible Municipal Income Fund II | |||
| ADIV | 17.78 | 0.04 | +0.23% |
| SmartETFs Asia Pcfc Dvdnd Bldr ETF | |||
| HYLS | 41.84 | 0.02 | +0.05% |
| First Trust Tactical High Yield ETF | |||
| CRSH | 4.73 | N/A | N/A |
| YieldMax Short TSLA Option Income Strategy ETF | |||
| IFGL | 22.76 | -0.03 | -0.13% |
| iShares International Dev Real Est ETF | |||
CURE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CURE has been loosely correlated with IQV. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CURE jumps, then IQV could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
|---|---|---|---|---|
| CURE | 100% | N/A | ||
| IQV - CURE | 65% Loosely correlated | -0.25% | ||
| GEHC - CURE | 63% Loosely correlated | -0.07% | ||
| TMO - CURE | 59% Loosely correlated | +0.37% | ||
| MRK - CURE | 57% Loosely correlated | -1.77% | ||
| JNJ - CURE | 56% Loosely correlated | +0.29% | ||
More | ||||
SPXL and
Correlation & Price change
A.I.dvisor indicates that over the last year, SPXL has been loosely correlated with MSFT. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPXL jumps, then MSFT could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To SPXL | 1D Price Change % | ||
|---|---|---|---|---|
| SPXL | 100% | +2.27% | ||
| MSFT - SPXL | 63% Loosely correlated | +1.58% | ||
| AAPL - SPXL | 62% Loosely correlated | +0.52% | ||
| AMZN - SPXL | 60% Loosely correlated | +1.59% | ||
| META - SPXL | 59% Loosely correlated | N/A | ||
| NVDA - SPXL | 56% Loosely correlated | +1.33% | ||
More | ||||